Previous 10 | Next 10 |
Evercore ISI has set up its list of key catalysts for the rest of 2021 in the biotechnology sector - including early-stage data readouts as well as some important legal and regulatory updates ahead for particular companies. Along the way it tees up its rule of thumb on biotech catalysts: "Alw...
Topline results from both studies are expected in December 2021 BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory c...
Gainers: MRIN +72.9%. ALPN +22.5%. SFIX +12.8%. PRAX +5.4%. LAUR +3.3%. Losers: SMMT -19.8%. LPTX -11.4%. BDSI -8.8%. BLU -5.2%. ATAX -4.2%. For further details see: MRIN, ALPN, SMMT and LPTX among after hours movers
Healthcare stocks in the S&P 500 edged past the ~0.6% loss in the broader index over the week to end ~0.2% lower, becoming the fourth best performing sector. Among stocks with more than $300M market cap and over 100K average daily volume over the past five sessions, BELLUS Health (NA...
The following slide deck was published by BELLUS Health Inc. in conjunction with this event. For further details see: BELLUS Health (BLU ) Investor Presentation - Slideshow
Although markets have been strong lately and many stocks are at or near their 52-week high, there are still plenty of high-quality Canadian stocks to consider today. Many growth stocks offer investors attractive opportunities, and these companies all come from several industries differe...
A $12B merger highlighted Tuesday's midday trading, as Intuit (NASDAQ:INTU) reached a deal to buy Mailchimp. Comcast (NASDAQ:CMCSA) represented another high-profile name making headlines. The stock dipped after the company's CFO tempered expectations for subscriber additions. Mission Produce ...
Gainers: Communications Systems (NASDAQ:JCS) +33%. BELLUS Health (NASDAQ:BLU) +20%. Matinas BioPharma (NYSE:MTNB) +19%. Onion Global (NYSE:OG) +18%. FuelCell Energy (NASDAQ:FCEL) +17%. Silverback Therapeutics (NASDAQ:SBTX) +16%. DatChat (NASDAQ:DATS) +15%. Calumet (NASDAQ:CLMT) +15%. Ada...
Shares of BELLUS Health (TSX:BLU) (NASDAQ:BLU) went gangbusters on the TSX today after management announced “positive findings” in a treatment for refractory chronic cough (RCC). Shares of the company jumped 30% by early Tuesday afternoon and continue to climb....
Gainers: BELLUS Health (NASDAQ:BLU) +26%, aTyr Pharma (NASDAQ:LIFE) +22%, Jounce Therapeutics (NASDAQ:JNCE) +14%, NanoViricides (NYSE:NNVC) +12%, Matinas BioPharma (NYSE:MTNB) +12%. Losers: Virpax Pharmaceuticals (NASDAQ:VRPX) -37%, RedHill Bi...
News, Short Squeeze, Breakout and More Instantly...
BELLUS Health Inc. Company Name:
BLU Stock Symbol:
NYSE Market:
Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS Health Canada NewsWire LONDON , June 28, 2023 /CNW/ - GSK plc (LSE: GSK) (NYSE: GSK) and BELLUS Health Inc. (TSX: BLU) NASDAQ: BLU) today announced GSK has completed ...
BELLUS Health Inc. (Nasdaq: BLU; TSX: BLU.TO) (“ BELLUS ” or the “ Company ”) today announced the positive outcome of the BELLUS shareholders (“ Shareholders ”) vote at this morning’s special meeting of the Shareholders (the “ ...
Special Meeting to be held on June 16, 2023 BELLUS Health Inc. (Nasdaq: BLU; TSX: BLU.TO) (“ BELLUS ” or the “ Company ”) today announced that the Superior Court of Québec has issued an interim order authorizing, among other things, the holding o...